(Q39164788)

9 September 2017

Cytotoxic T cell polyepitope vaccines delivered by ISCOMs (English)

1 reference

9 September 2017

0 references

Le TT

1

1 reference

9 September 2017

Drane D

2

1 reference

9 September 2017

Malliaros J

3

1 reference

9 September 2017

Cox JC

4

1 reference

9 September 2017

Rothel L

5

1 reference

9 September 2017

Pearse M

6

1 reference

9 September 2017

Woodberry T

7

1 reference

9 September 2017

Gardner J

8

1 reference

9 September 2017

Suhrbier A

9

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

9 September 2017

1 reference

9 September 2017

19

1 reference

9 September 2017

4669-4675

1 reference

9 September 2017

32

1 reference

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

ISCOMs: an adjuvant with multiple functions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

Iscoms Containing PurifiedQuillajaSaponins Upregulate both Th1-like and Th2-like Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900243-2

7 January 2021

10.1016/S0264-410X(01)00243-2

Identifiers

DOI

1 reference

9 September 2017

1 reference